Cannabis use frequency and its impact on monocyte-mediated inflammation in HIV patients
大麻使用频率及其对艾滋病毒患者单核细胞介导的炎症的影响
基本信息
- 批准号:10647734
- 负责人:
- 金额:$ 51.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:AIDS dementiaAgonistAnti-Inflammatory AgentsAstrocytesAutomobile DrivingAutopsyBlood - brain barrier anatomyCNR1 geneCNR2 geneCannabidiolCannabinoidsCannabisCell DeathCellsChronicCoculture TechniquesEventExhibitsFCGR3B geneFrequenciesGlutamatesHIVHIV InfectionsHIV-associated neurocognitive disorderHealthHumanIL18 geneImmunohistocytochemistryImpairmentIndividualInfiltrationInflammasomeInflammationInflammatoryInterleukin-1 betaLife ExpectancyLigandsMediatingNeurocognitive DeficitNeuronsPathway interactionsPatientsPersonsPropertyProteinsRegulationReportingRoleSurfaceTestingTetrahydrocannabinolantiretroviral therapybrain tissuecell typechronic infectionin vivomarijuana usemicrobialmigrationmonocyteneuroinflammationneurotoxicresponsesystemic inflammatory responsetranscriptomics
项目摘要
PROJECT SUMMARY/ABSTRACT
An estimated 37 million people worldwide are infected with human immunodeficiency virus (HIV). Combined
antiretroviral therapy (ART) has turned HIV into a chronic infection with significantly longer life expectancy.
New health issues have surfaced as HIV patients live longer. Specifically, 50% of HIV-infected (HIV+)
individuals exhibit neurocognitive impairment, termed HIV-associated neurocognitive disorder (HAND). A key
event leading to HAND is persistent low-level chronic inflammation resulting in neuronal damage and cell
death. A major contributor to HIV-induced neuroinflammation is activated monocytes, which are significantly
elevated in patients’ with HIV-associated dementia (HAD). A hallmark of HIV infection is chronic, systemic
inflammation in part through translocation of microbial derived products from the gut which, activates
monocytes and promote migration across the blood-brain barrier (BBB). Upon entry, activated monocytes
release neurotoxic and proinflammatory factors (e.g., IL-1), which are thought to contribute to HAND.
Recently, evidence has emerged implicating the importance of inflammasome activation as a contributing
mechanism to neuroinflammation and HAND. Preliminary results presented in this application show that
inflammasome activation in monocytes, as evidenced by IL-1 secretion, promotes astroglial cell inflammation.
These findings support a critical role for inflammasome activation in monocytes as a mechanism driving
neuroinflammation. In particular, immunohistocytochemistry of brain tissue from post-mortem HIV patients with
HAD showed significant infiltration of proinflammatory CD16+ monocytes. By contrast, cannabinoid exposure
displays anti-inflammatory properties in HIV-infected patients, which we and others have reported. The anti-
inflammatory properties of cannabis are attributed largely to the canonical ligand, ∆9-tetrahydrocannabinol
(THC), which exerts psychotropic activity through cannabinoid receptor (CB) 1 and the non-psychotropic-
mediating CB2, while cannabidiol (CBD) does not act through CB1/CB2. Likewise, the CB2 selective agonist,
JWH-015, represents a potential strategy for understanding the role of CB2 in limiting HIV-associated
neuroinflammation. In fact, preliminary results demonstrate that a CB2 selective agonist impairs monocyte
secretion of IL-1, a hallmark of inflammation and inflammasome activation. Mechanistic studies are proposed
to test the hypothesis: CD16+ monocytes from non-cannabis using HIV+ subjects exhibit greater
inflammasome formation and subsequent astrocyte activation compared to cannabis using HIV+ subjects,
which is associated with the frequency of cannabis use.
项目总结/摘要
据估计,全世界有3 700万人感染了人体免疫缺陷病毒(艾滋病毒)。组合
抗逆转录病毒疗法(ART)已将艾滋病毒变成一种慢性感染,预期寿命大大延长。
随着艾滋病毒感染者寿命的延长,新的健康问题也浮出水面。50%的艾滋病毒感染者(HIV+)
个体表现出神经认知损害,称为HIV相关的神经认知障碍(HAND)。一个关键
导致HAND的事件是持续性低水平慢性炎症,导致神经元损伤和细胞凋亡。
死亡HIV诱导的神经炎症的一个主要贡献者是活化的单核细胞,其显著地
HIV相关性痴呆(HAD)患者中,艾滋病毒感染的一个标志是慢性、系统性
炎症部分通过肠道微生物衍生产物的移位,
单核细胞和促进迁移通过血脑屏障(BBB)。一旦进入,激活的单核细胞
释放神经毒性和促炎因子(例如,IL-1 β),其被认为有助于HAND。
最近,有证据表明炎性小体激活作为一种促进
神经炎症和手的机制。本申请中提出的初步结果表明,
如IL-1 β分泌所证实的,单核细胞中的炎性小体活化促进星形胶质细胞炎症。
这些发现支持单核细胞中炎性小体激活作为驱动炎症反应的机制的关键作用。
神经炎症特别是,从尸检的HIV患者脑组织的免疫组织化学,
HAD显示显著的促炎性CD 16+单核细胞浸润。相比之下,
在HIV感染患者中显示抗炎特性,我们和其他人已经报道过。反-
大麻的炎症特性主要归因于典型的配体,β 9-四氢大麻酚
(THC),它通过大麻素受体(CB)1和非精神活性-
大麻二酚(CBD)不通过CB 1/CB 2起作用。同样,CB 2选择性激动剂,
JWH-015,代表了一种了解CB 2在限制HIV相关性疾病中的作用的潜在策略。
神经炎症事实上,初步结果表明,CB 2选择性激动剂损害单核细胞
IL-1 β的分泌是炎症和炎性小体活化的标志。提出了机理研究
为了检验这一假设:来自使用HIV+的非大麻受试者的CD 16+单核细胞表现出更大的
与使用大麻的HIV+受试者相比,
这与大麻的使用频率有关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Norbert E Kaminski其他文献
Norbert E Kaminski的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Norbert E Kaminski', 18)}}的其他基金
Cannabis use frequency and its impact on monocyte-mediated inflammation in HIV patients
大麻使用频率及其对艾滋病毒患者单核细胞介导的炎症的影响
- 批准号:
10153106 - 财政年份:2021
- 资助金额:
$ 51.45万 - 项目类别:
Cannabis use frequency and its impact on monocyte-mediated inflammation in HIV patients
大麻使用频率及其对艾滋病毒患者单核细胞介导的炎症的影响
- 批准号:
10472461 - 财政年份:2021
- 资助金额:
$ 51.45万 - 项目类别:
IUTOX 15th International Congress of Toxicology
IUTOX 第十五届国际毒理学大会
- 批准号:
9804800 - 财政年份:2019
- 资助金额:
$ 51.45万 - 项目类别:
Cannabinoids Modulate Immune Cell-provoked Astrocyte Functions to Suppress HIV-Associated Neuroinflammatory Responses
大麻素调节免疫细胞引发的星形胶质细胞功能,抑制 HIV 相关的神经炎症反应
- 批准号:
10619501 - 财政年份:2018
- 资助金额:
$ 51.45万 - 项目类别:
Cannabinoids Modulate Immune Cell-provoked Astrocyte Functions to Suppress HIV-Associated Neuroinflammatory Responses
大麻素调节免疫细胞引发的星形胶质细胞功能,抑制 HIV 相关的神经炎症反应
- 批准号:
9920700 - 财政年份:2018
- 资助金额:
$ 51.45万 - 项目类别:
Immunotoxicology of Chronic Exposure to Estrogenic Bisphenol-A
长期接触雌激素双酚 A 的免疫毒理学
- 批准号:
8477192 - 财政年份:2011
- 资助金额:
$ 51.45万 - 项目类别:
Immunotoxicology of Chronic Exposure to Estrogenic Bisphenol-A
长期接触雌激素双酚 A 的免疫毒理学
- 批准号:
8685982 - 财政年份:2011
- 资助金额:
$ 51.45万 - 项目类别:
Immunotoxicology of Chronic Exposure to Estrogenic Bisphenol-A
长期接触雌激素双酚 A 的免疫毒理学
- 批准号:
8230321 - 财政年份:2011
- 资助金额:
$ 51.45万 - 项目类别:
Immunotoxicology of Chronic Exposure to Estrogenic Bisphenol-A
长期接触雌激素双酚 A 的免疫毒理学
- 批准号:
8334564 - 财政年份:2011
- 资助金额:
$ 51.45万 - 项目类别:
THC impairment of CD4/CD8 T cell-mediated host resistance to HIV and influenza
THC 损害 CD4/CD8 T 细胞介导的宿主对 HIV 和流感的抵抗力
- 批准号:
7934666 - 财政年份:2009
- 资助金额:
$ 51.45万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 51.45万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 51.45万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 51.45万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 51.45万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 51.45万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 51.45万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 51.45万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 51.45万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 51.45万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 51.45万 - 项目类别:
Grant-in-Aid for Scientific Research (C)